Physician profile
Robert Shaw
NPI 1184715724
$690.48
in general payments reported to CMS, 2019-2025
10 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $46.07 · 2021: $11.99 · 2022: $46.70 · 2023: $75.07 · 2024: $48.95 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $277.12 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Pfizer INC. | $165.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $56.63 | 2019-2020 | |
| Allergan, INC. | $46.70 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.93 | 2019 | |
| Merck Sharp & Dohme LLC | $35.52 | 2019-2021 | |
| Novo Nordisk INC | $30.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.45 | 2019 | |
| Lilly USA, LLC | $12.15 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.